These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15908538)

  • 41. Magnetic resonance enterography with and without biphasic contrast agent enema compared to conventional ileocolonoscopy in patients with Crohn's disease.
    Friedrich C; Fajfar A; Pawlik M; Hoffstetter P; Rennert J; Agha A; Jung EM; Ott C; Stroszczynski C; Schreyer AG
    Inflamm Bowel Dis; 2012 Oct; 18(10):1842-8. PubMed ID: 22231897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hydro-MRI in Crohn's disease: appraisal of disease activity.
    Schunk K; Kern A; Oberholzer K; Kalden P; Mayer I; Orth T; Wanitschke R
    Invest Radiol; 2000 Jul; 35(7):431-7. PubMed ID: 10901105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MR enterography correlates highly with colonoscopy and histology for both distal ileal and colonic Crohn's disease in 310 patients.
    Grand DJ; Kampalath V; Harris A; Patel A; Resnick MB; Machan J; Beland M; Chen WT; Shah SA
    Eur J Radiol; 2012 May; 81(5):e763-9. PubMed ID: 22445795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diffusion-weighted MR enterography for evaluating Crohn's disease: how does it add diagnostically to conventional MR enterography?
    Kim KJ; Lee Y; Park SH; Kang BK; Seo N; Yang SK; Ye BD; Park SH; Kim SY; Baek S; Ha HK
    Inflamm Bowel Dis; 2015 Jan; 21(1):101-9. PubMed ID: 25358063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging with ferumoxil, a negative superparamagnetic oral contrast agent, in the evaluation of ulcerative colitis.
    D'Arienzo A; Scaglione G; Vicinanza G; Manguso F; Bennato R; Belfiore G; Imbriaco M; Mazzacca G
    Am J Gastroenterol; 2000 Mar; 95(3):720-4. PubMed ID: 10710064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pigmented villonodular synovitis (PVNS) of the knee joint: magnetic resonance imaging (MRI) using standard and dynamic paramagnetic contrast media. Report of 52 cases surgically and histologically controlled.
    Barile A; Sabatini M; Iannessi F; Di Cesare E; Splendiani A; Calvisi V; Masciocchi C
    Radiol Med; 2004 Apr; 107(4):356-66. PubMed ID: 15103287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Active Crohn's disease in the small bowel: evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging.
    Oto A; Kayhan A; Williams JT; Fan X; Yun L; Arkani S; Rubin DT
    J Magn Reson Imaging; 2011 Mar; 33(3):615-24. PubMed ID: 21563245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MR enteroclysis using iron oxide particles (ferristene) as an endoluminal contrast agent: an open phase III trial.
    Boraschi P; Braccini G; Gigoni R; Cartei F; Perri G
    Magn Reson Imaging; 2004 Oct; 22(8):1085-95. PubMed ID: 15527995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy.
    Samuel S; Bruining DH; Loftus EV; Becker B; Fletcher JG; Mandrekar JN; Zinsmeister AR; Sandborn WJ
    Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1253-9. PubMed ID: 22503995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of magnetic resonance imaging and endoscopy in distinguishing the type and severity of inflammatory bowel disease.
    Shoenut JP; Semelka RC; Magro CM; Silverman R; Yaffe CS; Micflikier AB
    J Clin Gastroenterol; 1994 Jul; 19(1):31-5. PubMed ID: 7930430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mural attenuation in normal small bowel and active inflammatory Crohn's disease on CT enterography: location, absolute attenuation, relative attenuation, and the effect of wall thickness.
    Baker ME; Walter J; Obuchowski NA; Achkar JP; Einstein D; Veniero JC; Vogel J; Stocchi L
    AJR Am J Roentgenol; 2009 Feb; 192(2):417-23. PubMed ID: 19155404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [MRI in Crohn's disease after transduodenal contrast administration using negative oral MRI contrast media].
    Holzknecht N; Helmberger T; Herrmann K; Ochsenkühn T; Göke B; Reiser M
    Radiologe; 2003 Jan; 43(1):43-50. PubMed ID: 12552374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel.
    Pascu M; Roznowski AB; Müller HP; Adler A; Wiedenmann B; Dignass AU
    Inflamm Bowel Dis; 2004 Jul; 10(4):373-82. PubMed ID: 15475745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computed tomography enteroclysis in comparison with ileoscopy in patients with Crohn's disease.
    Hassan C; Cerro P; Zullo A; Spina C; Morini S
    Int J Colorectal Dis; 2003 Mar; 18(2):121-5. PubMed ID: 12548413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of conventional enteroclysis, intestinal ultrasound and MRI-enteroclysis for determining changes in the small intestine and complications in patients with Crohn's disease].
    Schmidt T; Reinshagen M; Brambs HJ; Adler G; Rieber A; V Tirpitz C; Kratzer W
    Z Gastroenterol; 2003 Jul; 41(7):641-8. PubMed ID: 12858235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective comparison study of MRI versus small bowel follow-through in recurrent Crohn's disease.
    Bernstein CN; Greenberg H; Boult I; Chubey S; Leblanc C; Ryner L
    Am J Gastroenterol; 2005 Nov; 100(11):2493-502. PubMed ID: 16279905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [MRI with oral filling in patients with chronic inflammatory bowel diseases].
    Born C; Nagel B; Leinsinger G; Reiser M
    Radiologe; 2003 Jan; 43(1):34-42. PubMed ID: 12552373
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens.
    Tielbeek JA; Ziech ML; Li Z; Lavini C; Bipat S; Bemelman WA; Roelofs JJ; Ponsioen CY; Vos FM; Stoker J
    Eur Radiol; 2014 Mar; 24(3):619-29. PubMed ID: 24037299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity.
    Tielbeek JA; Makanyanga JC; Bipat S; Pendsé DA; Nio CY; Vos FM; Taylor SA; Stoker J
    AJR Am J Roentgenol; 2013 Dec; 201(6):1220-8. PubMed ID: 24261360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI.
    Pupillo VA; Di Cesare E; Frieri G; Limbucci N; Tanga M; Masciocchi C
    Radiol Med; 2007 Sep; 112(6):798-809. PubMed ID: 17885739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.